ORLEXUS
LIVE

Serial Number

79003890

Owner

BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG

Filing Date

May 5, 2004

Add to watchlist:

No watchlists yet
View on USPTO

ORLEXUS Trademark

Serial Number: 79003890 • Registration: 2992696

ORLEXUS is a trademark filed by BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG on May 5, 2004. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (105 trademarks)

BINGER STRASSE 173
55216 Ingelheim am Rhein , DE

Entity Type: 03

Trademark Details

Filing Date

May 5, 2004

Registration Date

September 6, 2005

Published for Opposition

June 14, 2005

Cancellation Date

May 5, 2014

Goods & Services

Pharmaceutical preparations and substances for the treatment of diseases and of the alimentary tract and metabolism, blood and blood forming organs, the cardiovascular system, the musculoskeletal system, the central nervous system, the peripheral nervous system, the genito-urinary system, the respiratory system, and dermatological disorders; hormones for medical purposes; anti-infective preparations; anti-viral preparations; cytostatic preparations for use in the treatment of cancer

Filing History

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jun 4, 2015 INNA
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Nov 28, 2014 DENC
DEATH OF INTERNATIONAL REGISTRATION
Nov 28, 2014 DETH
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 30, 2014 INTR
CANCELLED SECTION 71
Aug 30, 2013 C71T
CHANGE OF OWNER RECEIVED FROM IB
Sep 25, 2009 CHLD
REGISTERED-PRINCIPAL REGISTER
Sep 6, 2005 R.PR
PUBLISHED FOR OPPOSITION
Jun 14, 2005 PUBO
NOTICE OF PUBLICATION
May 25, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 19, 2005 PREV
ASSIGNED TO LIE
Feb 11, 2005 ALIE
ASSIGNED TO LIE
Dec 13, 2004 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 6, 2004 CNSA
ASSIGNED TO EXAMINER
Dec 2, 2004 DOCK
NEW APPLICATION ENTERED
Aug 16, 2004 NWAP
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 12, 2004 REPR